101 related articles for article (PubMed ID: 10903738)
1. IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentiation of the CD8 alpha+ subset.
Grohmann U; Bianchi R; Belladonna ML; Silla S; Fallarino F; Fioretti MC; Puccetti P
J Immunol; 2000 Aug; 165(3):1357-63. PubMed ID: 10903738
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells.
Grohmann U; Fallarino F; Silla S; Bianchi R; Belladonna ML; Vacca C; Micheletti A; Fioretti MC; Puccetti P
J Immunol; 2001 Jan; 166(1):277-83. PubMed ID: 11123303
[TBL] [Abstract][Full Text] [Related]
3. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase.
Grohmann U; Fallarino F; Bianchi R; Belladonna ML; Vacca C; Orabona C; Uyttenhove C; Fioretti MC; Puccetti P
J Immunol; 2001 Jul; 167(2):708-14. PubMed ID: 11441074
[TBL] [Abstract][Full Text] [Related]
4. IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivo.
Grohmann U; Bianchi R; Belladonna ML; Vacca C; Silla S; Ayroldi E; Fioretti MC; Puccetti P
J Immunol; 1999 Sep; 163(6):3100-5. PubMed ID: 10477575
[TBL] [Abstract][Full Text] [Related]
5. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
Bianchi R; Grohmann U; Belladonna ML; Silla S; Fallarino F; Ayroldi E; Fioretti MC; Puccetti P
J Immunol; 1996 Aug; 157(4):1589-97. PubMed ID: 8759743
[TBL] [Abstract][Full Text] [Related]
6. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state.
Grohmann U; Bianchi R; Ayroldi E; Belladonna ML; Surace D; Fioretti MC; Puccetti P
J Immunol; 1997 Apr; 158(8):3593-602. PubMed ID: 9103420
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant.
Orabona C; Belladonna ML; Vacca C; Bianchi R; Fallarino F; Volpi C; Gizzi S; Fioretti MC; Grohmann U; Puccetti P
J Immunol; 2005 Jun; 174(11):6582-6. PubMed ID: 15905495
[TBL] [Abstract][Full Text] [Related]
8. IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells.
Stober D; Schirmbeck R; Reimann J
J Immunol; 2001 Jul; 167(2):957-65. PubMed ID: 11441104
[TBL] [Abstract][Full Text] [Related]
9. Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses.
Fukao T; Frucht DM; Yap G; Gadina M; O'Shea JJ; Koyasu S
J Immunol; 2001 Apr; 166(7):4446-55. PubMed ID: 11254700
[TBL] [Abstract][Full Text] [Related]
10. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.
Grohmann U; Bianchi R; Orabona C; Fallarino F; Vacca C; Micheletti A; Fioretti MC; Puccetti P
J Immunol; 2003 Sep; 171(5):2581-7. PubMed ID: 12928409
[TBL] [Abstract][Full Text] [Related]
11. CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells.
Schulz O; Pennington DJ; Hodivala-Dilke K; Febbraio M; Reis e Sousa C
J Immunol; 2002 Jun; 168(12):6057-65. PubMed ID: 12055214
[TBL] [Abstract][Full Text] [Related]
12. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides.
Kavanagh B; Ko A; Venook A; Margolin K; Zeh H; Lotze M; Schillinger B; Liu W; Lu Y; Mitsky P; Schilling M; Bercovici N; Loudovaris M; Guillermo R; Lee SM; Bender J; Mills B; Fong L
J Immunother; 2007 Oct; 30(7):762-72. PubMed ID: 17893568
[TBL] [Abstract][Full Text] [Related]
14. Reduced antigen concentration and costimulatory blockade increase IFN-gamma secretion in naive CD8+ T cells.
Hall HT; Petrovic J; Höglund P
Eur J Immunol; 2004 Nov; 34(11):3091-101. PubMed ID: 15384046
[TBL] [Abstract][Full Text] [Related]
15. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
16. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo.
Manickasingham S; Reis e Sousa C
J Immunol; 2000 Nov; 165(9):5027-34. PubMed ID: 11046031
[TBL] [Abstract][Full Text] [Related]
17. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells.
Fukao T; Matsuda S; Koyasu S
J Immunol; 2000 Jan; 164(1):64-71. PubMed ID: 10604994
[TBL] [Abstract][Full Text] [Related]
19. IL-12 induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10.
Huang LY; Reis e Sousa C; Itoh Y; Inman J; Scott DE
J Immunol; 2001 Aug; 167(3):1423-30. PubMed ID: 11466361
[TBL] [Abstract][Full Text] [Related]
20. Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function.
Poligone B; Weaver DJ; Sen P; Baldwin AS; Tisch R
J Immunol; 2002 Jan; 168(1):188-96. PubMed ID: 11751962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
